Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) to Ring The Nasdaq Stock Market Closing Bell
November 14 2016 - 9:41AM
What:Achillion Pharmaceuticals,
Inc. (Nasdaq:ACHN), a science-driven, patient-focused company
seeking to leverage its strengths across the continuum from
discovery to commercialization in its goal of providing better
treatments for people with serious diseases, will visit the Nasdaq
MarketSite in Times Square.
In honor of the occasion, Dr. Milind S. Deshpande,
President and Chief Executive Officer, will ring the
Closing Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Tuesday, November 15, 2016 – 3:45 p.m. to
4:00 p.m. ET
Achillion Pharmaceuticals,
Inc. Contact:Liz Power203 752
5509Lpower@achillion.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West18 mhz LowerDL 3811 VerticalFEC
3/4SR 13.235DR 18.295411MOD 4:2:0DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Achillion PharmaceuticalsAchillion
Pharmaceuticals, Inc. (Nasdaq:ACHN) is a science-driven,
patient-focused company seeking to leverage its strengths across
the continuum from discovery to commercialization in its goal of
providing better treatments for people with serious diseases. The
company employs a highly-disciplined discovery and development
approach that has allowed it to pursue best-in-class oral antiviral
therapy for chronic hepatitis C (HCV) and build a platform of
potent and specific complement inhibitors. Achillion is rapidly
advancing its efforts to become a fully-integrated pharmaceutical
company with a goal of bringing life-saving medicines to patients
with rare diseases. More information is available
at http://www.achillion.com
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
provider of trading, clearing, exchange technology, listing,
information and public company services across six continents.
Through its diverse portfolio of solutions, Nasdaq enables
customers to plan, optimize and execute their business vision with
confidence, using proven technologies that provide transparency and
insight for navigating today's global capital markets. As the
creator of the world's first electronic stock market, its
technology powers more than 70 marketplaces in 50 countries, and 1
in 10 of the world's securities transactions. Nasdaq is home to
more than 3,700 listed companies with a market value of $10
trillion and approximately 18,000 corporate clients. To learn more,
visit: nasdaq.com/ambition or business.nasdaq.com
-NDAQA-
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Sep 2023 to Sep 2024